The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH)
- 15 August 2011
- journal article
- review article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (16), 4674-4685
- https://doi.org/10.1016/j.bmcl.2011.06.096
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (DA015648)
This publication has 111 references indexed in Scilit:
- Fluoride-Mediated Capture of a Noncovalent Bound State of a Reversible Covalent Enzyme Inhibitor: X-ray Crystallographic Analysis of an Exceptionally Potent α-Ketoheterocycle Inhibitor of Fatty Acid Amide HydrolaseJournal of the American Chemical Society, 2011
- Fatty acid amide signaling moleculesBioorganic & Medicinal Chemistry Letters, 2010
- A Second Generation of Carbamate‐Based Fatty Acid Amide Hydrolase Inhibitors with Improved Activity in vivoChemMedChem, 2009
- Characterization of Monoacylglycerol Lipase Inhibition Reveals Differences in Central and Peripheral Endocannabinoid MetabolismCell Chemical Biology, 2009
- Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH)Bioorganic & Medicinal Chemistry Letters, 2009
- Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory PainCell Chemical Biology, 2009
- Correlation of inhibitor effects on enzyme activity and thermal stability for the integral membrane protein fatty acid amide hydrolaseBioorganic & Medicinal Chemistry Letters, 2008
- Exploration of a fundamental substituent effect of α-ketoheterocycle enzyme inhibitors: Potent and selective inhibitors of fatty acid amide hydrolaseBioorganic & Medicinal Chemistry Letters, 2008
- Enzymatic Pathways That Regulate Endocannabinoid Signaling in the Nervous SystemChemical Reviews, 2008
- Delineation of a Fundamental α-Ketoheterocycle Substituent Effect for Use in the Design of Enzyme InhibitorsJournal of the American Chemical Society, 2006